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S. Pasupathy* and S. Homer-VanniasinkamVascular Surgical Unit, Leeds General Infirmary, Great George Street, Leeds, West Yorkshire LS1 3EX, UKIntroduction. Ischaemic preconditioning (IP) has emerged as a powerful method of ameliorating ischaemia/reperfusion
(I/R) injury to the myocardium. This review investigates whether this phenomenon is universally applicable in modulating
I/R injury to other tissues.
Methods. A Medline search was conducted to identify both animal and human studies that described IP-induced protection
from I/R injury in a variety of non-cardiac organ systems. Particular emphasis was placed on elucidation of underlying
physiological concepts.
Results and conclusions. IP utilises endogenous mechanisms in skeletal muscle, liver, lung, kidney, intestine and brain in
animal models to convey varying degrees of protection from I/R injury. To date there are few human studies, but recent
reports suggest that human liver, lung and skeletal muscle acquire similar protection after IP. Specifically, preconditioned
tissues exhibit reduced energy requirements, altered energy metabolism, better electrolyte homeostasis and genetic re-
organisation, giving rise to the concept of ‘ischaemia tolerance’. IP also induces ‘reperfusion tolerance’ with less reactive
oxygen species and activated neutrophils released, reduced apoptosis and better microcirculatory perfusion compared to non-
preconditioned tissue. Systemic I/R injury is also diminished by preconditioning. IP is ubiquitous but more research is
required to fully translate these findings to the clinical arena.Keywords: Ischaemic preconditioning; Reperfusion injury; Myocardium; Skeletal muscle; Liver; Lung; Intestine; Brain;
Kidney.Introduction
Ischaemic injury to vital organs such as the heart, brain
and kidneys contributes significantly to morbidity and
mortality throughout the world.1 Deprived of oxygen-
carrying blood, cellular respiration slows down with
irreversible damage occurring within minutes in
tissues such as myocardium and liver.2 Rapid restor-
ation of the circulation, while essential to maintain life,
brings its own hazards. Alluded to by Haimovici3 in
the 1970s as the ‘myonephropathic metabolic syn-
drome’, the full extent of reperfusion-induced tissue
injury was demonstrated with startling effect by Parks
and Granger.4 Whilst ischaemic injury is mainly due to
oxygen-deprived cellular necrosis, reperfusion pro-
duces an inflammatory response that both heightensing author. Mr S. Pasupathy, Clinical Research Fellow,
gical Unit, The General Infirmary at Leeds, Great
, Leeds, West Yorkshire LS1 3EX, UK.
: s_pasu@hotmail.com
0106+ 10 $35.00/0 q 2005 Elsevier Ltd. All rights reserlocal damage and leads to systemic insult as well.
Various methods of limiting reperfusion injury have
been described including oxygen radical scavenging,
leucodepletion, induced hypothermia and controlled
reperfusion.5–8
In 1986, Murry and colleagues described the
phenomenon of ischaemic preconditioning (IP)
which proved to be one of the most powerful
methods of minimising ischaemia/reperfusion
(I/R) injury. Murry et al. demonstrated in the
canine heart that four cumulative 5 min ischaemic
periods, rather than worsening adenosine 5 0-tripho-
sphate (ATP) depletion and myocardial necrosis,
instead conferred protection from a further pro-
longed 40 min ischaemic insult.9 The zone of
infarcted myocardium in preconditioned dogs was
reduced by 70% compared to controls subjected
only to the 40 min coronary occlusion. These
experiments galvanised the cardiovascular scientific
community and were consistently reproducible
across different animal models.10–12Eur J Vasc Endovasc Surg 29, 106–115 (2005)
doi:10.1016/j.ejvs.2004.11.005, available online at http://www.sciencedirect.com onved.
Ischaemic Preconditioning and I/R Injury 107IP was effective within minutes, suggesting that
preformed mediators were responsible for its effects.
Locally released agonists such as adenosine, bradyki-
nin, catecholamines and opioids trigger this protective
response through various cell surface G-protein
coupled receptors.13 Redundancy built into the system
initially led investigators to publish conflicting reports
on the efficacy of these agonists. Kinases such as
protein kinase C, tyrosine kinase and p38MAPKinase
participate in the signalling pathway.14–16 The end-
effector of preconditioning remains elusive, although
mitochondrial ATP-sensitive potassium (KATP) chan-
nels appear to be involved.17
In 1993, it was reported that a second window of
protection (‘SWOP’) developed 12–24 h after the initial
preconditioning stimulus.18 Unlike early IP, which is
shortlived, lasting only about 2–3 h, this ‘SWOP’
remains protective for 48–96 h.19 However, the magni-
tude of protection is less and different mechanistic
pathways are responsible.20 Hence IP induces a
biphasic protection from I/R injury—an initial strong
protective stimulus that is brief and a later, less
powerful but longer lasting protection (Fig. 1).
Repeated preconditioning episodes are neither addi-
tive nor cumulative (Fig. 2).21
This stunning experimental data led to successful
clinical application of IP to coronary angioplasty and
coronary artery bypass grafting.22–24 The phenomenon
of IP is not confined to myocardial protection alone.
Recent clinical trials involving pulmonary and hepatic
surgery attest to the safety and efficacy of IP as a
therapeutic adjunct.25,26 However, clinical progress is
slow.
This review examines the mechanisms by which IP
ameliorates I/R injury in a variety of organ systems. A
Medline search using combinations of the key-words
‘ischaemic preconditioning’, ‘reperfusion injury’,Fig. 1. Biphasic protection induced b‘myocardium’, ‘brain’, ‘liver’, ‘lung’, ‘kidney’, ‘intes-
intestine’ and ‘skeletal muscle’ was carried out.
Additional articles were identified from reference
lists of recent topical reviews. The mechanisms of
protection are grouped under the headings of
‘ischaemia tolerance’ and ‘reperfusion tolerance’.
Of course, the sum total of post-ischaemic injury is
a combination of these two processes and the
relative contribution from each differs between
different organs.27 Indeed, many of the damaging
events that take place at the time of reperfusion are
secondary to critical changes that have already
occurred during the preceding ischaemic period.IP Induces ‘Ischaemia Tolerance’Metabolic inhibition allows cells to survive hypoxia: lessons
from comparative physiology
In hypoxia-tolerant systems, e.g. turtle hepatocytes,
anoxia leads to ‘metabolic arrest’, i.e. 90–100% sup-
pression of non-essential cellular activity, implying
that cells can survive 10 times longer on the same
amount of high-energy phosphates (HEP) available
(Summary Box 1).28 The dominant energy sink during
anoxia is the NaC pump which is responsible for
maintaining the high transmembrane NaC and KC
potential gradient. Even so, the activity of this pump
drops to only one-quarter of its normal rate because
the passive drift of ions across the plasma membrane
through non-energy dependent ion channels is
restricted; i.e. ‘membrane arrest’ occurs. These 2 key
defence strategies allow the hypoxia-tolerant cell to
adjust its energy balance to a new, lower steady-state
equilibrium.29 Indeed, ‘membrane arrest’ is observed
in hypoxia-sensitive tissues that receive IP. In a studyy a single preconditioning episode.
Eur J Vasc Endovasc Surg Vol 29, February 2005
Fig. 2.Multiple preconditioning episodes convert biphasic protection into a monophasic pattern. Note that the magnitude of
protection is not increased and the duration of protection is dictated by the last preconditioning stimulus.
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preconditioned cerebral tissue had lower whole-cell
conductance and potassium-channel activity in vitro
compared to non-preconditioned controls.30Energy sparing effect of IP
IP reduces cellular energy demand during ischae-
mia.31 Preconditioned in vivo canine hearts consumed
ATP slower than controls during the first 20 min of
sustained ischaemia. Although the rate of nucleotide
degradation gradually increased in both groups as
ischaemia progressed, the adenine nucleotide pool
was still greater in preconditioned tissue at the end of
40 min.32 Slower destruction of adenine nucelotides
and reduced glycolysis was concordant with the
period of ischaemic preconditioning, i.e. the dimin-
ished metabolic rate lasted for the 180 min or so that IP
rendered protection from subsequent ischaemia.Summary Box 1
Different physiological mechanisms by which
tolerance’. Ischaemia causes injury at a cellular
during hypoxic stress.
Passive drift of ions across plasma and mitochondria
Cellular energy demand reduced
ATP consumption reduced
Rate of glycolysis reduced
Intra-cellular energy relays become more efficient
Decreased production of HC ions
Maintenance of ionic equilibrium during prolonged h
Transformation to ‘hypoxia-tolerant’ phenotype
Eur J Vasc Endovasc Surg Vol 29, February 2005Investigators have shown similar high levels of
HEP, adenine nucleotides and glycolytic intermedi-
ates, and reduced accumulation of lactate and HC
after I/R in preconditioned porcine and murine
models.33,34 One possible mechanism by which metab-
olism can be downregulated is through adenosine 5 0-
monophosphate-activated protein kinase (AMPK),
which inhibits glycolysis in rat hepatocytes.35 Degra-
dation of ATP during IP leads to accumulation of
adenosine 5 0-monophosphate (AMP), an allosteric
activator of AMPK.36 Inhibition of AMPK production
abolished the protective effects of preconditioning on
energy metabolism and hepatocyte injury.37
ATP itself exerts allosteric inhibition of pyruvate
kinase, an important regulatory enzyme in glycoly-
sis.38 Maintaining higher levels of ATP during pro-
longed ischaemia allows preconditioned tissues to
reduce the rate of glycolysis. CyclicAMP dependent
protein kinase phosphorylation of another regulatory
enzyme complex phosphofructo-2-kinase/fructose-ischaemic preconditioning induces ‘ischaemia
level. Ischaemic preconditioning protects cells
l membranes restricted
ypoxia
Ischaemic Preconditioning and I/R Injury 1092,6-bisphosphatase also controls glycolytic rates
during prolonged ischaemia.39 In a study on rat liver,
brief ischaemia led to increased production of cycli-
cAMP in sinusoidal endothelial cells.40IP enhances efficiency of phosphotransfer networks (energy
relays)
The elucidation of the tricarboxylic acid cycle41 and
chemiosmotic theory42 have directed our understand-
ing of energy transactions, enzyme kinetics and ion
transfer across mitochondria. An emerging concept in
cellular energetics is the use of phosphotransfer
networks to effectively link sources of energy pro-
duction with sites of utilisation. The cell is not just a
‘watery bag of enzymes’.43 Movement of adenine
nucleotides by diffusion is both kinetically and
haemodynamically inefficient as it requires a signifi-
cant concentration gradient.44 In actual fact, ATP
produced in the tight folds of the mitochondrial
inner membrane is rapidly shuttled by near-equili-
brium enzymatic flux transfer relays and high-
throughput contact sites between inner and outer
mitochondrial membranes.45 ATP production is
coupled efficiently to sites of utilisation by key enzyme
pathways including creatine kinase, adenylate kinase
and glycolytic enzymes. Nuclear magnetic resonance
(NMR) spectroscopic analysis of the relative distri-
bution of HEP intermediates in rat myocardium
demonstrated that IP increased efficiency of these
phosphotransfer networks.46IP improves acid–base and ion balance during hypoxia
Depletion of ATP during sustained ischaemia can lead
to failure of the NaC/KC ATPase pump and NaC
influx from the extra-cellular space, resulting in cell
swelling and rupture. Production of HC from the
hydrolysis of glycolytically derived ATP contributes to
acidosis in severely ischaemic tissues.47 Recovery of
intracellular pH during reperfusion can give rise to
significant influx of NaC and CaCC (via the NaC/HC,
NaC/CaCC transporters) with disastrous conse-
quences.48 IP has a direct effect in maintaining
intra-cellular ion homeostasis and acid–base balance
following prolonged ischaemia. Intracellular NaC
accumulation and acidosis were prevented in precondi-
tioned rat hepatocytes subject to sustained anoxia.49
Ionic equilibrium across the inner and outer
mitochondrial membranes is also critical in maintain-
ing cellular integrity.50 IP allows mitochondrial KATP
channels to remain open during subsequent ischae-
mia, reducing calcium accumulation in the matrix.51Can mammalian tissues undergo transformation to a
hypoxia-tolerant phenotype?
Brief periods of ischaemia initiate transformation to a
hypoxia-tolerant state in mammalian tissues. Tran-
scription factors such as NF-kB and AP-1 and the
immediate early genes c-fos and c-jun are upregulated
after hypoxia.52–54 Perhaps, as if having received an
early-warning signal, hypoxia-sensitive cells carry out
crucial genetic rearrangements to not only withstand
further assault, but also to continue optimal perform-
ance of vital functions.
IP reprogrammed the genomic response of neonatal
mouse brain to ischaemia, reflecting endogenous
neuroprotective responses similar to that seen in
hibernation and hypoxia-tolerant organisms.30 Nf-kB
activation, acting via p38 MAPkinase allowed pre-
conditioned hepatocytes to enter the cell cycle upon
exposure to prolonged ischaemia.55 This development
of an adaptive phenotype is speculated to be a critical
biological step favouring survival against further I/R
injury.
Transcriptional targets include heat shock pro-
teins(HSP)—cellular chaperones that maintain struc-
tural and functional integrity of nuclear and
cytoplasmic proteins—which increase 50-fold 48 h
after preconditioning ischaemia in rat hepatocytes.56
In a recent report, 30 min of bilateral preconditioning
ischaemia to mouse kidneys improved post-ischaemic
renal function and reduced post-ischaemic leucocyte
infiltration and actin cytoskeleton disruption for 12
weeks.57IP Induces ‘Reperfusion Tolerance’Protection from oxidative stress
Reperfusion, although essential to restore oxidative
phosphorylation in hypoxic tissues and remove
accumulated waste products, has serious local and
systemic consequences (Summary Box 2).58 Free
oxygen radicals, produced during the degradation of
xanthine by xanthine oxidase (XO), are a major
contributor to reperfusion injury. In healthy tissue,
90% of this enzyme is in the dehydrogenase (XD) form.
Calcium activated proteases catalyse the conversion of
XD to XO in endothelial cells during hypoxia.59 This
sets the stage for generation of reactive oxygen species
(ROS). Bulkley27 suggested that these ROS are
intended to be signalling molecules that trigger the
reticulo-endothelial system as part of a protective
immune response against microbes. (That thisEur J Vasc Endovasc Surg Vol 29, February 2005
Summary Box 2
Different physiological mechanisms by which ischaemic preconditioning induces ‘reperfusion
tolerance’. Reperfusion can paradoxically result in worsening of the pre-existing ischaemic injury to
not only the entire organ but the organism as a whole. This is partly due to induction of the
inflammatory cascade. During reperfusion, ischaemic preconditioning renders protection at the
cellular, organ and systemic level.
Mechanism of protection Level of protection
Reduced production of free oxygen radicals Cellular, organ, systemic
Maintenance of intra-cellular redox potential Cellular
Reduction of reperfusion-induced apoptosis Cellular
Preservation of mitochondrial integrity during reperfusion Cellular
Diminution of the ‘no-reflow’ phenomenon Organ, systemic
Reduction of activated leucocytes and cytokine production Organ, systemic
S. Pasupathy and S. Homer-Vanniasinkam110conversion occurs more readily in the gut than in the
heart60 may lend some credence to this hypothesis.)
However, the return of oxygenated blood produces
large amounts of ROS that, in addition to activating
leucocytes, also directly contribute to tissue injury by
lipid peroxidation of membranes.
Preconditioned rat livers subjected to cold ischae-
mia had reduced conversion of XD to XO,61 attenuat-
ing oxidant stress during reperfusion. Not only did
preconditioned grafts have reduced hepatic damage
after liver transplantation, but the recipient rats also
suffered less pulmonary injury. Similar moderation of
oxidative stress was observed in murine skeletal
muscle and intestine.62,63 In a clinical trial of patients
undergoing pulmonectomy, those randomised to IP
had significantly higher levels of superoxide dismu-
tase, an enzyme that reduces free radicals, following
surgery.25
Kupfer cells are the dominant producers of ROS in
the liver.64 IP reduced Kupfer cell activation and
leucocyte-endothelial interaction, and preserved mito-
chondrial redox potential in rat livers.65 IP also exerts a
direct cytoprotective effect from oxidant stress. Pre-
conditioned rat hepatocytes had greater resistance to
hydrogen peroxide-mediated cytotoxicity.66 In separ-
ate experiments, hepatocytes were exposed to stimu-
lated Kupfer cells and exogenous hydrogen peroxide
infusion (both of which produced abundant ROS). In
both studies, preconditioned cells sustained less injury
and preserved their intra-cellular thiol status (an
indicator of the anti-oxidant potential).IP can inhibit apoptotic cell death
Apoptosis or ‘programmed cell death’ is increasingly
recognised as an important form of cell death after
reperfusion.67 The mechanism of this type of self-Eur J Vasc Endovasc Surg Vol 29, February 2005regulation has been remarkably conserved down the
eukaryotic line. Caspases, or cysteine aspartyl-specific
proteases, are the central components in a complex
process of ‘ritual suicide’.68 Members of the Bcl-2
family of proteins, on the other hand, are crucial
integrators of survival and death signals, somehow
registering diverse forms of intracellular damage and
integrating these competing signals to determine
whether the cell is ‘to be or not to be’.69 Post-ischaemic
tissues produce tumour necrosis factor-a (TNF-a),
which is a crucial inducer of apoptosis in the liver.70
IP decreased reperfusion-induced hepatic apoptosis
by lowering TNF-a levels and modulating the caspase
dependent pathway.71 Apoptosis was attenuated in
the preconditioned rat kidney, intestine and brain after
I/R injury.72–74 In a non-randomised study of 24
patients undergoing hepatic resection, the precondi-
tioned group had dramatically lower levels of apop-
totic sinusoidal lining cells.75 In another clinical trial of
16 patients undergoing pulmonectomy, patients ran-
domised to receive IP had significantly increased
expression of Bcl-2 in lung tissue exposed to I/R
injury and consequently, a reduced apoptosis index.76
Although the interrelationship between cell death
promoters and inhibitors is complex, mitochondria
appear to be critical in coordinating these events.IP preserves mitochondrial integrity during reperfusion
Mitochondria play an important part in energy
production through oxidative phosphorylation, intra-
cellular ROS generation, calcium homeostasis and
release of apoptosis-inducing factors (AIF).77 These
functions give mitochondria a central role in deter-
mining cellular fate after stress,78 but exactly how they
induce cytoprotection is unclear. Mitochondrial KATP
channels regulate apoptosis induced by oxidative
Ischaemic Preconditioning and I/R Injury 111stress.79 These channels play a key role in regulating
calcium51 and ATP levels,80 both in the mitochondrial
matrix and in the cytoplasm.
Preconditioned rat hearts released less mitochon-
drial AIF after I/R injury.81 Activation of mitochon-
drial KATP channels after IP was protective in murine,
rabbit and canine organs exposed to subsequent I/R.17,
82,83 Another possible mechanism of protection is by
inhibition of mitochondrial permeability transition
pores (MPTP).84 Opening of these pores within a few
minutes of reperfusion in conditions of increased
CaCC and Pi, ATP depletion, oxidative stress and
increased matrix pH, can initiate apoptotic cell
death.85 In a Langendorff-perfused rat heart model,
IP inhibited initial MPTP opening in hearts reperfused
after 30 min of global ischaemia.86Preventing ‘no-reflow’: IP protects the microcirculation
during reperfusion
The no-reflow phenomenon upon reperfusion of
ischaemic tissue can inhibit the full return of nutritive
perfusion.87 Up to 30% of the vascular bed can remain
non-perfused, further potentiating ischaemic injury.
Post-ischaemic endothelial cell swelling, up-regu-
lation of adhesion molecules, reduced nitric oxide
(NO) bioavailability and platelet and neutrophil
activation are contributary factors.88
Preconditioning reduced arteriolar vasospasm and
capillary no-reflow in animal models.33,83 Precondi-
tioned rats exposed to experimental transient ischae-
mic attack (TIA) had enhanced arachidonic acid
metabolism, with increased production of vasodilat-
ing eicosanoids, enabling better brain perfusion and
reduction of cerebral infarcts by more than 50%.
Kharbanda et al. demonstrated preservation of endo-
thelial vasoregulatory function in preconditioned
human forearm skeletal muscle following tourniquet
ischaemia.89
NO produced by endothelial cells plays an import-
ant physiological role in maintaining the calibre of
blood vessels and its reduced release is one of the
earliest signs of reperfusion induced endothelial
dysfunction.90 High levels of NO following precondi-
tioning inhibited the effects of vasoconstrictor pep-
tides such as endothelin released after hepatic I/R
injury.91
Reduced ‘stickiness’ of post-ischaemic neutrophils
in preconditioned tissue has been attributed to
diminished I/R-induced P-selectin expression92 and
downregulation of inter-cellular adhesion molecule(I-
CAM)-1 release.93 Intra-vital microscopy demon-
strated attenuated leucocyte adhesion andemigration in preconditioned rodent skeletal muscle
and feline mesentery compared to controls subjected
only to I/R.94,95Systemic Protective Effects of IP: Defence Against
Re-circulation of Activated Cells and Toxic
Metabolites
Reperfusion allows endothelial and inflammatory
cytokines released during hypoxic stress to be circu-
lated to the entire body. For example, TNF-a produced
after hepatic I/R injury can lead to adhesion molecule
expression and leukocyte infiltration in the pulmonary
circulation.96 Potentially toxic amounts of metabolites
accumulated during ischaemia also enter the circula-
tion, e.g. KC, HC, lactate and bradykinin.97 Neutro-
phils which become activated in the I/R bed have the
potential to cause serious injury in the lung and
kidney, providing the basis for systemic complications
such as the adult respiratory distress syndrome and
acute renal failure.98
Preconditioned rat liver had significantly reduced
production of TNF-a from Kupffer cells.96 In remote
organs this led to reduced P-selectin expression and
hence decreased neutrophil adhesion and infiltration.
IP before acute limb ischaemia in pigs led to less severe
systemic effects, i.e. reduced circulating interleukin-6
levels, primed phagocytes, leukosequestration, pul-
monary oedema and respiratory failure.99 IP of murine
mesenteric circulation 24 h prior to induced haemor-
rhagic shock attenuated the systemic inflammatory
response syndrome and reduced bacterial transloca-
tion from post-ischaemic intestine.100,101 Kharbanda et
al. demonstrated attenuated neutrophil activation in
healthy human volunteers who received IP before
tourniquet-induced I/R injury to forearm muscle.89Clinical Implications
Pioneering use of ischaemic preconditioning in cardiac
surgery by Yellon et al. brought this technique into the
clinical arena as a surgical adjunct (Table 1).23,24 This
group demonstrated that two 3 min periods of IP prior
to coronary artery bypass grafting could reduce
myocardial injury (measured by troponin levels)
caused by the procedure. During hepatic-resectional
surgery, Clavien et al. and Nuzzo et al. have demon-
strated similar protection for residual liver.26,75,102 The
other specialty in which IP has been used operatively
is pulmonary surgery. In separate clinical trials, Chen
et al. applied clamps to the main pulmonary artery
prior to pulmonectomy and intra-operativeEur J Vasc Endovasc Surg Vol 29, February 2005
Table 1. Current evidence for ischaemic preconditioning in human
organs
Organ Level of evidence References
Heart Clinical trial 19,24
Liver Clinical trial 26,75,102
Lung Clinical trial 25,76
Brain Epidemiological
evidence
104–107
Skeletal Muscle In vivo experimental
studies
89,103
S. Pasupathy and S. Homer-Vanniasinkam112chemotherapy for unresectable lung cancer.25,76 In all
of the clinical situations in which IP has been utilised, a
reduction in tissue injury and improvement in post-
operative organ function has been demonstrated.
Skeletal muscle is well known to be relatively
tolerant of ischaemia, but Kharbanda et al. have shown
that both local and remote IP reduce neutrophil
activation and endothelial dysfunction in healthy
human volunteers subjected to forearm I/R injury.89,
103 No clinical studies have been carried out in patients
with peripheral arterial disease, although epidemio-
logical evidence points towards IP conferring protec-
tion following cerebral ischaemia. Patients who
experienced transient ischaemic attacks (TIAs) prior
to sustaining strokes, were found to have more
favourable neurological recovery in three studies
from Germany.104–106 Despite suffering similar per-
fusion deficits, magnetic resonance imaging (MRI)
confirmed that patients who experienced a preceding
TIA developed smaller-volume cerebral infarcts.107
This evidence raises intriguing possibilities about
effecting endogenous ischaemia-protection in humans.
For example, perhaps carotid endarterectomy surgery
is best carried out within a few days of a TIA? More
clinical trials are clearly required to investigate these
issues. Indeed, one of the more profound influences of
research into the phenomenon of preconditioning is
likely to be a deeper understanding of the various
pathways by which the insults of ischaemia and
reperfusion cause injury.Conclusions
The phenomenon of ischaemic preconditioning is
ubiquitous. Both early and late forms of IP utilise
endogenous pathways in various organ systems to
render protection from subsequent I/R injury. Pre-
formed agonists such as adenosine, bradykinin,
catecholamines and opioids trigger the early protec-
tive response, while the delayed preconditioning effect
is initiated by genetic re-arrangements resulting in
altered cell physiology. Neurogenic pathways are alsoEur J Vasc Endovasc Surg Vol 29, February 2005important in transmitting protective signals. Precondi-
tioned tissues are therefore better equipped than
ischaemia-naı¨ve organs to withstand the two-pronged
assault of I/R injury.
During ischaemia, IP-treated tissues exhibit
reduced energy requirements, conservation of energy
substrates, diminished metabolism and tighter regu-
lation of acid–base and ion balance. Upon exposure to
reperfusion, preconditioned tissues demonstrate a
reduction in oxidative stress, neutrophil activation,
cytokine production and apoptosis, and enhanced
microcirculatory perfusion. Appreciating the enthral-
ling mechanisms that organisms previously thought to
be highly sensitive to hypoxia, including our own
genotype, have evolved to deal with this two-pronged
assault can allow the early promise of IP to become full
clinical reality.References
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